Article ; Online: Do maternal haemodynamics have a causal influence on treatment for gestational diabetes?
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
2024 Volume 44, Issue 1, Page(s) 2307883
Abstract: Background: Arterial stiffening is believed to contribute to the worsening of insulin resistance, and factors which are associated with needing pharmacological treatment of gestational diabetes (GDM), such as maternal obesity or advanced age, are ... ...
Abstract | Background: Arterial stiffening is believed to contribute to the worsening of insulin resistance, and factors which are associated with needing pharmacological treatment of gestational diabetes (GDM), such as maternal obesity or advanced age, are associated with impaired cardiovascular adaptation to pregnancy. In this observational study, we aimed to investigate causal relationships between maternal haemodynamics and treatment requirement amongst women with GDM. Methods: We assessed maternal haemodynamics in women with GDM, comparing those who remained on dietary treatment with those who required pharmacological management. Maternal haemodynamics were assessed using the Arteriograph® (TensioMed Ltd, Budapest, Hungary) and the NICOM® non-invasive bio-reactance method (Cheetah Medical, Portland, Oregon, USA). A graphical causal inference technique was used for statistical analysis. Results: 120 women with GDM were included in the analysis. Maternal booking BMI was identified as having a causative influence on treatment requirement, with each unit increase in BMI increasing the odds of needing metformin and/or insulin therapy by 12% [OR 1.12 (1.02 - 1.22)]. The raw values of maternal heart rate (87.6 ± 11.7 vs. 92.9 ± 11.90 bpm, Conclusions: Maternal BMI at booking has a causal, rather than simply associational, relationship on the need for pharmacological treatment of GDM. No significant causal relationships were found between maternal haemodynamics and the need for pharmacological treatment. |
---|---|
MeSH term(s) | Pregnancy ; Female ; Humans ; Diabetes, Gestational/drug therapy ; Metformin/therapeutic use ; Hemodynamics ; Risk Factors ; Insulin/therapeutic use |
Chemical Substances | Metformin (9100L32L2N) ; Insulin |
Language | English |
Publishing date | 2024-02-22 |
Publishing country | England |
Document type | Observational Study ; Journal Article |
ZDB-ID | 604639-3 |
ISSN | 1364-6893 ; 0144-3615 |
ISSN (online) | 1364-6893 |
ISSN | 0144-3615 |
DOI | 10.1080/01443615.2024.2307883 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2461: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.